Oncology Institute (TOIIW) Current Leases (2022 - 2026)

Oncology Institute (TOIIW) has reported Current Leases for 5 consecutive years, with $7.4 million the latest figure, recorded in Q1 2026.

• Current Leases for Q1 2026 came in at $7.4 million, up 8.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.4 million (up 8.63% YoY), and the FY2025 annual result was $7.2 million, up 5.27% from the prior year.
• Current Leases was $7.4 million for Q1 2026 at Oncology Institute, up from $7.2 million in the prior quarter.
• Over five years, Current Leases peaked at $7.4 million in Q1 2026 and troughed at $4.3 million in Q1 2022.
• Average Current Leases over 5 years is $6.2 million, with a median of $6.4 million recorded in 2024.
• Year-over-year, Current Leases jumped 33.77% in 2023 and increased 5.27% in 2025.
• Over 5 years, Current Leases stood at $5.5 million in 2022, then gained by 15.73% to $6.4 million in 2023, then increased by 6.84% to $6.8 million in 2024, then climbed by 5.27% to $7.2 million in 2025, then rose by 3.47% to $7.4 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $7.4 million in Q1 2026, $7.2 million in Q4 2025, and $7.2 million in Q3 2025.